This pilot trial studies how well a resistance training program and cardiovascular exercise work in increasing muscle mass in adolescent and young adult stem cell transplant survivors. Resistance training and cardiovascular exercise may increase physical activity, muscular strength and improve lean body mass which is beneficial to improving the overall health of stem cell transplant survivors.
PRIMARY OBJECTIVES: I. Determine the feasibility of a 12-week resistance training (RT) intervention in adolescent and young adult (AYA) hematopoietic cell transplant (HCT) survivors starting +100 days post-HCT. SECONDARY OBJECTIVES: I. Examine the change from baseline of a RT intervention on muscle strength and body composition at day +200 and day +365. II. Determine the effectiveness of RT exercise on improving the cardio-metabolic risk factor profile at day +200 and day +365. III. Determine the effectiveness of RT exercise on improving quality of life (QOL) measures. IV. Compare day +80 and day +365 assessments to subjects in a historical control population. OUTLINE: Patients undergo moderately intense aerobic/cardiovascular exercise over 30-60 minutes and complete 1-2 sets of 8 to 10 resistance/strength training exercises, 8 to 12 repetitions of each exercise, 3 days per week for 12 weeks. Patients also participate in weekly phone calls with an exercise physiologist to ensure adherence to the program and to provide support. After completion of study intervention, patients are followed up within 2 weeks, then at 365 days post HCT.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Enrollment
20
Undergo resistance training program and cardiovascular exercise
Ancillary studies
Ancillary studies
Fred Hutch/University of Washington Cancer Consortium
Seattle, Washington, United States
Enrollment rate
Percentage of eligible, approached patients enrolling in program
Time frame: 200 Days
Completion rate
Percentage of enrolled participants completing the full intervention
Time frame: At day +200 post hematopoietic cell transplant (HCT)
Adherence rate
Percentage of participants completing weekly follow-up phone calls
Time frame: At day +200 post hematopoietic cell transplant (HCT)
Change in physical activity
Measured using Actigraph activity monitor
Time frame: Baseline to day +365 post HCT
Change in physical activity
International Physical Activity Questionnaire (IPAQ)
Time frame: Baseline to day +365 post HCT
Change in anthropometrics (BMI)
Measured by BMI; weight and height will be combined to report BMI in kg/m\^2
Time frame: Baseline to day +365 post HCT
Change in cardiometabolic profile (Fasting Glucose, Insulin and Lipid Profile)
Testing will be performed on patient blood samples. Changes will be calculated as score (approximately day +200) - score (approximately day+100). All variables will be described based on their distributions (means, standard deviations if normally distributed, medians and IQRs otherwise). A t-test will be used to compare means between baseline and follow-up time periods.
Time frame: Baseline to day +365 post HCT
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Participate in phone calls with exercise physiologist
Heart rate
Time frame: Baseline to day +365 post HCT
Change in body composition
Measured using dual-energy x-ray absorptiometry (DXA). Changes will be calculated as score (approximately day +200) - score (approximately day+100). All variables will be described based on their distributions (means, standard deviations if normally distributed, medians and IQRs otherwise). A t-test will be used to compare means between baseline and follow-up time periods.
Time frame: Baseline to day +365 post HCT
Change in muscular strength
Strength testing will include hand grip strength, one repetition maximum chest press, one repetition maximum leg press and the 6 minute walk test. Changes will be calculated as score (approximately day +200) - score (approximately day +100). All variables will be described based on their distributions (means, standard deviations if normally distributed, medians and IQRs otherwise). A t-test will be used to compare means between baseline and follow-up time periods.
Time frame: Baseline to day +365 post HCT
Blood pressure
Time frame: Baseline to day +365 post HCT
Change in quality of life (QOL)
Measured by the Patient-Reported Outcomes Measurement Information System
Time frame: Baseline to day +365 post HCT
Incidence of adverse events
Time frame: Up to day +200 post HCT